Cover Image
市場調查報告書

僵直性脊椎炎 (AkS):主要13個國家的市場預測

Epiomic Epidemiology Series: Ankylosing Spondylitis Forecast in 13 Major Markets 2017-2027

出版商 Black Swan Analysis 商品編碼 482918
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
僵直性脊椎炎 (AkS):主要13個國家的市場預測 Epiomic Epidemiology Series: Ankylosing Spondylitis Forecast in 13 Major Markets 2017-2027
出版日期: 2017年03月01日 內容資訊: 英文 70 Pages
簡介

本報告提供全球主要13個國家的僵直性脊椎炎 (AkS)的發病情形相關分析,疾病概要和目前的患病人數,各子類型及性別、各年代 (5歲劃分)的詳細情況,各地區、各民族趨勢,風險要素,疾病診斷與預後,主要的症狀和併發症 (乾癬,葡萄膜炎,發炎性腸道疾病 (IBD),附著部炎,肺纖維化,心血管疾病 (DVC),前列腺炎 (男性),脊椎骨折等),未來趨勢預測 (今後10年份) 的資訊彙整。

目錄

  • 圖表一覽
  • 簡介
  • 疾病的原因
  • 風險要素與預防法
  • 疾病診斷方法
  • 各地區/各民族的差異
  • 疾病的預後和臨床過程
  • 疾病相關的主要的共生病症/特徵
  • 患者數的測量方法
  • 僵直性脊椎炎 (AkS)的最大患病人數
  • 僵直性脊椎炎患者的特徵
  • 僵直性脊椎炎的主要的症狀
  • 僵直性脊椎炎患者的共生病症
  • 僵直性脊椎炎患者的脊椎骨折
  • 文中的簡稱一覽
  • Black Swan Analysis的其他出版刊物
  • Black Swan Analysis的線上、病患人數的資料庫
  • 病患人數的服務
  • 線上價格資料/平台
  • 參考文獻
  • 附錄

圖表一覽

分析觀察對象國家

  • 巴西
  • 加拿大
  • 中國
  • 法國
  • 德國
  • 印度
  • 義大利
  • 日本
  • 俄羅斯
  • 西班牙
  • 土耳其
  • 英國
  • 美國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: AKSP0010317

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Ankylosing Spondylitis in 13 Major Markets

Ankylosing Spondylitis (AkS) is a chronic, systemic inflammatory autoimmune disease. It primarily affects the sacro-iliac joints of the hip and pelvis, but extends to the axial skeleton. Patients experience low back pain and increased stiffness.

This report provides the current prevalent population for Ankylosing Spondylitis across 13 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Russia, Turkey, Brazil, Japan, India and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Ankylosing Spondylitis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

There are several features associated with Ankylosing Spondylitis, these include:

  • Psoriasis
  • Uveitis
  • IBD
  • Enthesitis
  • peripheral arthritis
  • Pulmonary fibrosis
  • CVD (aortic root / rheumatic heart / AV block and other conduction disorders)
  • Prostatitis (males)
  • Spinal ankylosis and fracture

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy:

  • Able to quantify patient populations in global Ankylosing Spondylitis market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Ankylosing Spondylitis and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Ankylosing Spondylitis prevalent
  • Identify sub-populations within Ankylosing Spondylitis which require
  • Gain an understanding of the specific markets that have the largest number of Ankylosing Spondylitis patients.

Coverage:

BR, CA, CN, FR, DE, IN, IT, JP, RU, ES, TR, UK, US.

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key comorbid conditions/Features associated with the disease
  • Methodology for quantification of patient numbers
  • Top-line prevalence for Ankylosing Spondylitis
  • Features of Ankylosing Spondylitis Patients
    • Major Symptoms of Ankylosing Spondylitis
    • Comorbid conditions of Ankylosing Spondylitis patients
    • Vertebral fractures in patients with Ankylosing Spondylitis
  • Abbreviations used in the report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix

List of Figures

  • Spinal changes associated with Ankylosing Spondylitis

List of Tables

  • New York Criteria for diagnosis of Ankylosing Spondylitis
  • New York Criteria for grading sacroiliitis
  • Prevalence of Ankylosing Spondylitis, total (000s)
  • Prevalence of Ankylosing Spondylitis, males (000s)
  • Prevalence of Ankylosing Spondylitis, females (000s)
  • Spinal Radiographic Changes in AkS patients, total (000s)
  • Patients by likely origin of AkS, total (000s)
  • Cervical Rotation, total (000s)
  • Sacroliitis Grade (NY criteria), total (000s)
  • AkS patients by Smoking status, total (000s)
  • Ankylosing Spondylitis patients with HLA-B27 mutation, total (000s)
  • Ankylosing Spondylitis patients with Sarcoiliac pain, total (000s)
  • Ankylosing Spondylitis patients with Low back pain, total (000s)
  • Ankylosing Spondylitis patients with Enthesitis, total (000s)
  • Ankylosing Spondylitis patients with Dactylitis, total (000s)
  • Ankylosing Spondylitis patients with Peripheral Arthritis, total (000s)
  • Ankylosing Spondylitis patients with Anxiety, total (000s)
  • Ankylosing Spondylitis patients with Depression, total (000s)
  • Ankylosing Spondylitis patients with Urolithiasis, total (000s)
  • Ankylosing Spondylitis patients with Inflammatory Bowel Disease, total (000s)
  • Ankylosing Spondylitis patients with Psoriasis, total (000s)
  • Ankylosing Spondylitis patients with Uveitis, total (000s)
  • Ankylosing Spondylitis patients with Asthma, total (000s)
  • Ankylosing Spondylitis patients with Hay-fever, total (000s)
  • Ankylosing Spondylitis patients with Eczema, total (000s)
  • Ankylosing Spondylitis patients with Obstructive Sleep Apnoea, total (000s)
  • Ankylosing Spondylitis patients with Elevated CRP, total (000s)
  • Ankylosing Spondylitis patients with BASDAI ≥ 4, total (000s)
  • Ankylosing Spondylitis patients with Hip Involvement, total (000s)
  • Ankylosing Spondylitis patients with Bamboo Spine, total (000s)
  • Ankylosing Spondylitis patients with Pulmonary Abnormality on HRCT, total (000s)
  • Ankylosing Spondylitis patients with Cervical Spine Involvement, total (000s)
  • Ankylosing Spondylitis patients with First-Degree AV Block, total (000s)
  • Ankylosing Spondylitis patients with Prolonged QRS interval, total (000s)
  • Ankylosing Spondylitis patients with Shoulder Disorders, total (000s)
  • Ankylosing Spondylitis patients with Vertebral Fractures, total (000s)
  • Location of Vertebral Fractures in AkS patients, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • USA Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Canada Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Canada Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • France Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • France Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Germany Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Germany Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Italy Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Italy Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Spain Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Spain Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • UK Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • UK Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Turkey Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Turkey Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Japan Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Japan Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • India Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • India Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • China Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • China Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Russia Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Russia Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
Back to Top